基于CCDSS管理阿尔茨海默病患者对其生活能力及生存质量影响的效果评价  

Evaluation of the Effect of CCDSS-based Management on the Ability of Life and Quality of Life of Patients with Alzheimer’s Disease

作　　者：王波[1,2] 金雯 胡斌[1] 周健坤 WANG Bo;JIN Wen;HU Bin;ZHOU Jiankun(Department of Madical and Nursing,Tongling Polytechnic College,Tongling,Anhui,244061;Tongling RenheHospital,Tongling,Anhui,244061)

机构地区：[1]铜陵职业技术学院医学护理系,安徽铜陵244061 [2]铜陵市仁和医院,安徽铜陵244061

出　　处：《智慧健康》2022年第19期180-184,共5页Smart Healthcare

基　　金：安徽高校自然科学研究重点项目《Lnc RNA特异性基因异常表达对肝癌细胞增殖、迁移的影响及其相关信号通路作用机制的研究》(项目编号:KJ2020A0974);安徽省高等学校省级质量工程项目《外科护理学教师教学创新团队》(项目编号:2019cxtd043);安徽高校优秀青年人才支持计划重点项目《LncRNA异常表达对肝癌进展的影响及其在相关经典信号通路中作用机制的研究》(项目编号:gxydZD2021155);铜陵职业技术学院自然科学研究重点项目《基于计算机临床决策支持系统在铜陵市社区慢性病管理中的应用研究》(项目编号:tlpt2020NK008);铜陵市仁和医院“三新”项目《基于计算机临床决策支持系统在慢性病管理中的应用》(项目编号:铜仁医〔2021〕14号)。

摘　　要：目的探讨基于CCDSS的慢病管理对阿尔茨海默病患者生活能力及生存质量的影响。方法选取铜陵市仁和医院在2018年1月-2019年12月收治的轻、中度AD患者63例,采用抽签法分为CCDSS组32例和对照组31例。CCDSS组采用基于CCDSS的慢病管理对阿尔茨海默病患者实施干预,对照组采用常规治疗及护理。采用MMSE量表评定AD患者认知功能,ADL量表评估AD患者的生活能力,SF-36量表评估两组AD患者的生存质量,并比较两组患者的认知功能、生活能力和生存质量;随访并比较两组不良事件发生率。结果采用基于CCDSS的慢病管理干预后,两组患者干预前后MMSE评分无显著差异(P>0.05),但干预后CCDSS组患者PSMS评分、IADLs评分和SF-36评分均较干预前显著提高,且与对照组相比有显著差异(P<0.05);干预后CCDSS组不良事件发生率低于对照组,差异有统计学意义(P<0.05)。结论基于CCDSS的慢病管理可以改善阿尔茨海默病患者生活能力及生存质量,在慢病管理中值得深入研究。Objective To explore the effect of CCDSS-based chronic disease management on the ability of life and quality of life of patients with Alzheimer’s disease.Methods 63 patients with mild to moderate AD treated in Tongling Renhe Hospital from January 2018 to December 2019 were divided into CCDSS group(n=32)and control group(n=31).Patients with Alzheimer’s disease were intervened in CCDSS group with chronic disease management based on CCDSS,while patients in control group were treated with routine treatment and nursing.MMSE scale was used to evaluate the cognitive function of AD patients,ADL scale was used to evaluate the ability of life of AD patients,and SF-36 scale was used to evaluate the quality of life of two groups of AD patients,to compare the cognitive function,ability of life and quality of life of the two groups,following-up and comparing the incidence of adverse events between the two groups.Results After the CCDSS-based chronic disease management intervention,there was no significant difference in MMSE score between the two groups before and after intervention(P>0.05),but the PSMS score,IADLs score and SF-36 score in the CCDSS group were significantly higher than those before intervention,and there was significant difference compared with the control group(P<0.05).The incidence of adverse events in the CCDSS group was significantly lower than that in the control group after intervention(P<0.05).Conclusion CCDSSbased chronic disease management can improve the ability of life and quality of life of patients with Alzheimer’s disease,which is worthy of in-depth study in chronic disease management.

关 键 词：阿尔茨海默病 计算机化临床决策支持系统 生活能力 生存质量 

分 类 号：R473.74[医药卫生—护理学]